Payment overview · 2025
General Payments
$386.84
6 reported records · 4 companies
Healthcare provider profile · identity verified
Jack Janani, M.D.
Allopathic & Osteopathic Physicians|Hospitalist · BROOKLYN, NY · NPI 1285047092
Verified facts
What the public records show
CMS Open Payments records show Jack Janani, M.D. received $386.84 in general payments during 2025 across 6 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 51.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 101 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Trulicity by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 159 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Ozempic by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 159 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $200.94 | 51.9% | 3 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $125.00 | 32.3% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $38.54 | 10.0% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $22.36 | 5.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $348.30 | 5 |
| Education | $38.54 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $239.48 | 4 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $22.36 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $22.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 159 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
101 | 18 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
159 | 23 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
159 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2327 | 340 |
| Amlodipine Besylate | Amlodipine Besylate | 1337 | 208 |
| Eliquis | Apixaban | 1274 | 178 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1256 | 171 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1199 | 182 |
| Gabapentin | Gabapentin | 976 | 151 |
| Mirtazapine | Mirtazapine | 862 | 112 |
| Losartan Potassium | Losartan Potassium | 838 | 117 |
| Metoprolol Tartrate | Metoprolol Tartrate | 786 | 137 |
| Clopidogrel | Clopidogrel Bisulfate | 783 | 83 |
| Famotidine | Famotidine | 764 | 108 |
| Furosemide | Furosemide | 743 | 129 |
| Hydralazine Hcl | Hydralazine Hcl | 685 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 636 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 623 | 113 |
| Carvedilol | Carvedilol | 613 | 75 |
| Nifedipine Er | Nifedipine | 609 | 72 |
| Metformin Hcl | Metformin Hcl | 531 | 72 |
| Levetiracetam | Levetiracetam | 487 | 62 |
| Labetalol Hcl | Labetalol Hcl | 435 | 45 |
| Sevelamer Carbonate | Sevelamer Carbonate | 415 | 43 |
| Donepezil Hcl | Donepezil Hcl | 412 | 68 |
| Latanoprost | Latanoprost | 378 | 93 |
| Lisinopril | Lisinopril | 370 | 62 |
| Escitalopram Oxalate | Escitalopram Oxalate | 369 | 65 |
| Memantine Hcl | Memantine Hcl | 344 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 331 | 55 |
| Citalopram Hbr | Citalopram Hydrobromide | 294 | 43 |
| Finasteride | Finasteride | 293 | 40 |
| Midodrine Hcl | Midodrine Hcl | 288 | 41 |
| Sertraline Hcl | Sertraline Hcl | 282 | 38 |
| Entresto | Sacubitril/Valsartan | 275 | 34 |
| Simvastatin | Simvastatin | 271 | 40 |
| Xarelto | Rivaroxaban | 251 | 29 |
| Allopurinol | Allopurinol | 250 | 26 |
| Risperidone | Risperidone | 249 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 243 | 35 |
| Divalproex Sodium | Divalproex Sodium | 230 | 34 |
| Omeprazole | Omeprazole | 227 | 46 |
| Januvia | Sitagliptin Phosphate | 222 | 29 |
| Trazodone Hcl | Trazodone Hcl | 217 | 35 |
| Tradjenta | Linagliptin | 211 | 20 |
| Ammonium Lactate | Ammonium Lactate | 179 | 48 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 176 | 20 |
| Olanzapine | Olanzapine | 173 | 22 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 168 | 29 |
| Rexulti | Brexpiprazole | 159 | 23 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 149 | 40 |
| Brimonidine Tartrate | Brimonidine Tartrate | 147 | 31 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 136 | 36 |
| Spironolactone | Spironolactone | 136 | 24 |
| Calcium Acetate | Calcium Acetate | 133 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 130 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 21 |
| Lactulose | Lactulose | 117 | 40 |
| Clonidine Hcl | Clonidine Hcl | 115 | 13 |
| Ezetimibe | Ezetimibe | 114 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 113 | 37 |
| Farxiga | Dapagliflozin Propanediol | 113 | 15 |
| Potassium Chloride | Potassium Chloride | 110 | 23 |
| Enoxaparin Sodium | Enoxaparin Sodium | 109 | 17 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 108 | 24 |
| Prednisone | Prednisone | 107 | 31 |
| Aripiprazole | Aripiprazole | 105 | 20 |
| Santyl | Collagenase Clostridium Hist. | 105 | 34 |
| Valsartan | Valsartan | 105 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 104 | 40 |
| Jardiance | Empagliflozin | 101 | 18 |
| Buspirone Hcl | Buspirone Hcl | 99 | 19 |
| Baclofen | Baclofen | 98 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 17 |
| Montelukast Sodium | Montelukast Sodium | 96 | 20 |
| Enalapril Maleate | Enalapril Maleate | 95 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 90 | 30 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 88 | 34 |
| Metformin Hcl Er | Metformin Hcl | 88 | 11 |
| Amantadine | Amantadine Hcl | 83 | 17 |
| Calcitriol | Calcitriol | 83 | suppressed |
| Meloxicam | Meloxicam | 82 | 20 |
| Minoxidil | Minoxidil | 82 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 81 | 34 |
| Novolin R | Insulin Regular, Human | 81 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 79 | 12 |
| Enulose | Lactulose | 78 | 29 |
| Amiodarone Hcl | Amiodarone Hcl | 76 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 76 | 29 |
| Tramadol Hcl | Tramadol Hcl | 75 | 26 |
| Glipizide Er | Glipizide | 73 | 11 |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 72 | 16 |
| Bupropion Xl | Bupropion Hcl | 70 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 69 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 68 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 67 | suppressed |
| Myrbetriq | Mirabegron | 66 | suppressed |
| Glimepiride | Glimepiride | 65 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 65 | 14 |
| Alendronate Sodium | Alendronate Sodium | 63 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 63 | 26 |
| Torsemide | Torsemide | 63 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 61 | 19 |
| Methimazole | Methimazole | 61 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 60 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 60 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 58 | 17 |
| Brilinta | Ticagrelor | 58 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 56 | 17 |
| Nystatin | Nystatin | 56 | 18 |
| Repaglinide | Repaglinide | 56 | suppressed |
| Timolol Maleate | Timolol Maleate | 55 | 16 |
| Acyclovir | Acyclovir | 54 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 53 | 20 |
| Lamotrigine | Lamotrigine | 52 | suppressed |
| Atenolol | Atenolol | 50 | 11 |
| Lokelma | Sodium Zirconium Cyclosilicate | 49 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 48 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 48 | suppressed |
| Hydrocortisone | Hydrocortisone | 47 | 18 |
| Renvela | Sevelamer Carbonate | 47 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 47 | 22 |
| Humalog | Insulin Lispro | 44 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 44 | 12 |
| Colchicine | Colchicine | 43 | suppressed |
| Digoxin | Digoxin | 43 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 42 | suppressed |
| Rhopressa | Netarsudil Mesylate | 41 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 40 | 26 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 40 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 40 | suppressed |
| Folic Acid | Folic Acid | 40 | suppressed |
| Glipizide | Glipizide | 40 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 40 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Cilostazol | Cilostazol | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 26 |
| Sucralfate | Sucralfate | 38 | 11 |
| Lacosamide | Lacosamide | 37 | suppressed |
| Levocarnitine | Levocarnitine | 37 | suppressed |
| Linzess | Linaclotide | 37 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | 11 |
| Admelog Solostar | Insulin Lispro | 35 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | suppressed |
| Metolazone | Metolazone | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 16 |
| Nitroglycerin | Nitroglycerin | 32 | 13 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 32 | suppressed |
| Admelog | Insulin Lispro | 31 | 15 |
| Incruse Ellipta | Umeclidinium Bromide | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | suppressed |
| Ranolazine Er | Ranolazine | 31 | suppressed |
| Celecoxib | Celecoxib | 30 | suppressed |
| Ozempic | Semaglutide | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Alogliptin | Alogliptin Benzoate | 29 | 11 |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 28 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 28 | 14 |
| Cefazolin Sodium | Cefazolin Sodium | 27 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 27 | 13 |
| Prednisolone Acetate | Prednisolone Acetate | 27 | suppressed |
| Acetazolamide | Acetazolamide | 26 | suppressed |
| Creon | Lipase/Protease/Amylase | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Bumetanide | Bumetanide | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 25 | suppressed |
| Dutasteride | Dutasteride | 25 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 25 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 16 |
| Ondansetron Odt | Ondansetron | 25 | 12 |
| Silver Sulfadiazine | Silver Sulfadiazine | 25 | 11 |
| Topiramate | Topiramate | 25 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 24 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 23 | 14 |
| Ramipril | Ramipril | 23 | suppressed |
| Tacrolimus | Tacrolimus | 23 | suppressed |
| Vascepa | Icosapent Ethyl | 23 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | 12 |
| Lidocaine | Lidocaine | 22 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Anastrozole | Anastrozole | 20 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Erythromycin | Erythromycin Base | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | 11 |
| Silodosin | Silodosin | 20 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 19 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 19 | 13 |
| Zonisamide | Zonisamide | 19 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 18 | 15 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Novolog | Insulin Aspart | 18 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 17 | suppressed |
| Hydroxyurea | Hydroxyurea | 17 | suppressed |
| Lamivudine Hbv | Lamivudine | 17 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 17 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Xifaxan | Rifaximin | 17 | suppressed |
| Budesonide | Budesonide | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Humulin R | Insulin Regular, Human | 16 | suppressed |
| Klor-Con 10 | Potassium Chloride | 16 | suppressed |
| Ofloxacin | Ofloxacin | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Tivicay | Dolutegravir Sodium | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 15 |
| Diazepam | Diazepam | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 14 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Np Thyroid | Thyroid,pork | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 14 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 13 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Risperidone Er | Risperidone Microspheres | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Haloperidol Lactate | Haloperidol Lactate | 12 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Lubiprostone | Lubiprostone | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Vemlidy | Tenofovir Alafenamide | 12 | suppressed |
| Baqsimi | Glucagon | 11 | suppressed |
| Bicalutamide | Bicalutamide | 11 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 11 | suppressed |
| Procrit | Epoetin Alfa | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Ssd | Silver Sulfadiazine | 11 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $386.84 · 6 records | Otsuka America Pharmaceutical, Inc. | Ozempic, REXULTI, Rybelsus, ZEPBOUND | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error